Study of chemotherapy for patients with good prognosis metastatic non-seminomatous testicular cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN79658966

Enrollment

Registered

2001-02-28

Start date

1986-01-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Testicular cancer

Interventions

Arm 1: Bleomycin 30 mg x 3 per course, BEP x 4 Arm 2: Bleomycin 30 mg per course, BEP x 4

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Histologically proven non-seminomatous testicular cancer

Exclusion criteria

Exclusion criteria: Previous radiotherapy or chemotherapy

Design outcomes

Primary

Measure	Time frame
Toxicity/response	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026